Drugs / BLIS K12
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05043376 | Sep → Nov 2021 | COVID-19 | King Edward Medical University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BLIS K12 | “S. salivarius K12 strain, commonly known as BLIS K12” NCT05043376 ↗ |
| Modality | Other / unclassified | “probiotic Streptococcus salivarius K12” NCT05043376 ↗ |
| Route | Oral | “oral administration of the strain K12” NCT05043376 ↗ |